Literature DB >> 16113252

Porphyromonas gingivalis fimbria-dependent activation of inflammatory genes in human aortic endothelial cells.

Hsin-Hua Chou1, Hiromichi Yumoto, Michael Davey, Yusuke Takahashi, Takanari Miyamoto, Frank C Gibson, Caroline A Genco.   

Abstract

Epidemiological and pathological studies have suggested that infection with the oral pathogen Porphyromonas gingivalis can potentiate atherosclerosis and human coronary heart disease. Furthermore, infection with invasive, but not noninvasive P. gingivalis has been demonstrated to accelerate atherosclerosis in apolipoprotein E-deficient (ApoE(-/-)) mice and to accelerate local inflammatory responses in aortic tissue. In the present study, using high-density oligonucleotide microarrays, we have defined the gene expression profile of human aortic endothelial cells (HAEC) after infection with invasive and noninvasive P. gingivalis. After infection of HAEC with invasive P. gingivalis strain 381, we observed the upregulation of 68 genes. Genes coding for the cytokines Gro2 and Gro3; the adhesion molecules intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule (VCAM)-1, and ELAM-1 (E-selectin); the chemokine interleukin-8 (IL-8); and the proinflammatory molecules IL-6 and cyclooxygenase-2 were among the most highly upregulated genes in P. gingivalis 381-infected HAEC compared to uninfected HAEC control. Increased mRNA levels for signaling molecules, transcriptional regulators, and cell surface receptors were also observed. Of note, only 4 of these 68 genes were also upregulated in HAEC infected with the noninvasive P. gingivalis fimA mutant. Reverse transcription-PCR, enzyme-linked immunosorbent assay, and fluorescence-activated cell sorting analysis confirmed the expression of ICAM-1, VCAM-1, E-/P-selectins, IL-6, and IL-8 in HAEC infected with invasive P. gingivalis. We also demonstrated that increased expression of ICAM-1 and VCAM-1 in aortic tissue of ApoE(-/-) mice orally challenged with invasive P. gingivalis but not with the noninvasive P. gingivalis fimA mutant by immunohistochemical analysis. Taken together, these results demonstrate that P. gingivalis fimbria-mediated invasion upregulates inflammatory gene expression in HAEC and in aortic tissue and indicates that invasive P. gingivalis infection accelerates inflammatory responses directly in the aorta.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16113252      PMCID: PMC1231143          DOI: 10.1128/IAI.73.9.5367-5378.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

Review 1.  Interactions of Chlamydia pneumoniae with human endothelial cells.

Authors:  J T Summersgill; R E Molestina; R D Miller; J A Ramirez
Journal:  J Infect Dis       Date:  2000-06       Impact factor: 5.226

2.  cDNA array analysis of altered gene expression in human endothelial cells in response to Chlamydia pneumoniae infection.

Authors:  B K Coombes; J B Mahony
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

Review 3.  Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease.

Authors:  Murat V Kalayoglu; Peter Libby; Gerald I Byrne
Journal:  JAMA       Date:  2002-12-04       Impact factor: 56.272

4.  Selectin-P and interleukin-8 plasma levels in coronary heart disease patients.

Authors:  E Romuk; B Skrzep-Poloczek; C Wojciechowska; A Tomasik; E Birkner; J Wodniecki; B Gabrylewicz; A Ochala; M Tendera
Journal:  Eur J Clin Invest       Date:  2002-09       Impact factor: 4.686

5.  Role for fimbriae and lysine-specific cysteine proteinase gingipain K in expression of interleukin-8 and monocyte chemoattractant protein in Porphyromonas gingivalis-infected endothelial cells.

Authors:  Hamdy Nassar; Hsin-Hua Chou; Mary Khlgatian; Frank C Gibson; T E Van Dyke; Caroline Attardo Genco
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

6.  Fimbria-dependent activation of cell adhesion molecule expression in Porphyromonas gingivalis-infected endothelial cells.

Authors:  Mary Khlgatian; Hamdy Nassar; Hsin-Hua Chou; Frank C Gibson; Caroline Attardo Genco
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

7.  Identification of periodontal pathogens in atheromatous plaques.

Authors:  V I Haraszthy; J J Zambon; M Trevisan; M Zeid; R J Genco
Journal:  J Periodontol       Date:  2000-10       Impact factor: 6.993

8.  Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model.

Authors:  Li Li; Emmanuel Messas; Eraldo L Batista; Robert A Levine; Salomon Amar
Journal:  Circulation       Date:  2002-02-19       Impact factor: 29.690

Review 9.  Cell adhesion molecules in the pathogenesis of and host defence against microbial infection.

Authors:  J R Kerr
Journal:  Mol Pathol       Date:  1999-08

10.  Dephosphorylation targets Bcl-2 for ubiquitin-dependent degradation: a link between the apoptosome and the proteasome pathway.

Authors:  S Dimmeler; K Breitschopf; J Haendeler; A M Zeiher
Journal:  J Exp Med       Date:  1999-06-07       Impact factor: 14.307

View more
  33 in total

Review 1.  Activation and resolution of periodontal inflammation and its systemic impact.

Authors:  Hatice Hasturk; Alpdogan Kantarci
Journal:  Periodontol 2000       Date:  2015-10       Impact factor: 7.589

2.  Porphyromonas gingivalis infection-induced tissue and bone transcriptional profiles.

Authors:  A Meka; V Bakthavatchalu; S Sathishkumar; M C Lopez; R K Verma; S M Wallet; I Bhattacharyya; B F Boyce; M Handfield; R J Lamont; H V Baker; J L Ebersole; L Kesavalu
Journal:  Mol Oral Microbiol       Date:  2010-02       Impact factor: 3.563

3.  Invasion of epithelial cells and proteolysis of cellular focal adhesion components by distinct types of Porphyromonas gingivalis fimbriae.

Authors:  Ichiro Nakagawa; Hiroaki Inaba; Taihei Yamamura; Takahiro Kato; Shinji Kawai; Takashi Ooshima; Atsuo Amano
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

4.  Novel microarray design strategy to study complex bacterial communities.

Authors:  Antoine Huyghe; Patrice Francois; Yvan Charbonnier; Manuela Tangomo-Bento; Eve-Julie Bonetti; Bruce J Paster; Ignacio Bolivar; Denise Baratti-Mayer; Didier Pittet; Jacques Schrenzel
Journal:  Appl Environ Microbiol       Date:  2008-01-18       Impact factor: 4.792

5.  The Distinct Immune-Stimulatory Capacities of Porphyromonas gingivalis Strains 381 and ATCC 33277 Are Determined by the fimB Allele and Gingipain Activity.

Authors:  Stephen R Coats; Nutthapong Kantrong; Thao T To; Sumita Jain; Caroline A Genco; Jeffrey S McLean; Richard P Darveau
Journal:  Infect Immun       Date:  2019-11-18       Impact factor: 3.441

Review 6.  Bacterial invasion of vascular cell types: vascular infectology and atherogenesis.

Authors:  Emil Kozarov
Journal:  Future Cardiol       Date:  2012-01

7.  Molecular characterization of Treponema denticola infection-induced bone and soft tissue transcriptional profiles.

Authors:  V Bakthavatchalu; A Meka; S Sathishkumar; M C Lopez; R K Verma; S M Wallet; I Bhattacharyya; B F Boyce; J J Mans; R J Lamont; H V Baker; J L Ebersole; L Kesavalu
Journal:  Mol Oral Microbiol       Date:  2010-08       Impact factor: 3.563

Review 8.  Mechanisms involved in the association between periodontal diseases and cardiovascular disease.

Authors:  R Teles; C-Y Wang
Journal:  Oral Dis       Date:  2011-01-11       Impact factor: 3.511

9.  Human alpha- and beta-defensins bind to immobilized adhesins from Porphyromonas gingivalis.

Authors:  Deborah E Dietrich; Xiangjun Xiao; Deborah V Dawson; Myriam Bélanger; Hua Xie; Ann Progulske-Fox; Kim A Brogden
Journal:  Infect Immun       Date:  2008-10-13       Impact factor: 3.441

10.  Nasal immunization with Porphyromonas gingivalis outer membrane protein decreases P. gingivalis-induced atherosclerosis and inflammation in spontaneously hyperlipidemic mice.

Authors:  Y Koizumi; T Kurita-Ochiai; S Oguchi; M Yamamoto
Journal:  Infect Immun       Date:  2008-04-21       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.